g health 22

What struck researchers from the Brain Function Research Group (BFRG) at Wits University as odd was that despite this high burden of pain in HIV, a couple of papers have emerged suggesting that, having asked patients, functional interference (having difficulty with things like walking or going to work) was not as great as they might have expected. One of these papers was from the BFRG and had been completed locally in Johannesburg, South Africa.v To investigate whether pain does actually affect function in HIV (as it does in many other clinical conditions), researchers Dr Antonia Wadley, Emeritus Professor Duncan Mitchell and Associate Professor Peter Kamerman from the BFRG, based in the School of Physiology, Faculty of Health Sciences at Wits, conducted a cross-sectional study. The results from the study, titled "Resilience does not explain the dissociation between chronic pain and physical activity in South Africans living with HIV" are published in the journal  PeerJ...

A novel technique to display screen pregnant ladies for malaria with speedy diagnostic assessments and deal with the test-positive ladies with efficient antimalarials doesn't decrease the chance of hostile being pregnant outcomes in contrast with treating all pregnant ladies with the malaria preventive sulfadoxine-pyrimethamine (SP) in sub-Saharan Africa, in line with an open label randomized trial printed this week in  PLOS Medication  by Feiko ter Kuile, of the Liverpool Faculty of Tropical Medication, and colleagues. Throughout being pregnant, undetected an infection with malaria parasites can result in maternal anemia, low birthweight, and fetal loss. In areas the place malaria is endemic , the World Well being Group recommends treating pregnant ladies with SP, however in some areas, greater than 90 % of Plasmodium parasites are immune to SP. Within the new examine, the researchers in contrast this normal of care to a s...

The study -- known as the AMP study (for Antibody Meditated Prevention) -- will determine whether infusing an experimental antibody (VRC01) into HIV-negative men and transgender individuals who have sex with men, will prevent the acquisition of HIV. "This is landmark study," said Shobha Swaminathan, an infectious disease specialist and the NJMS-CRC site leader. "It is the first study of this magnitude to see whether an antibody infusion can help prevent new HIV infections. If it proves effective, it could potentially pave a way for developing a vaccine for HIV infection." Antibodies are one of the natural ways the human body fights infection. The antibody being studied was initially detected in an individual who was able to successfully control HIV infection without taking any medications for HIV. Subsequently, scientists at the NIH were able to model its structure and recreate this antibody in the laboratory. At the current time, HIV infections can be treat...